California’s Medicaid Scrutiny Shows a Shift in Healthcare Fraud Enforcement
The federal government’s healthcare fraud crackdown on the West Coast is no longer just an announcement.
Since the Department of Justice launched its West Coast Health Care Fraud Strike Force this spring, California has become an early test of what a more aggressive enforcement environment could look like. In July, the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services deferred approximately $867.5 million in federal Medicaid payments to California while the state provides additional documentation supporting certain in-home care claims. Federal officials emphasized that the action is a payment deferral, not a permanent funding cut.
For healthcare providers, operators, and insurers, the significance goes beyond the size of the deferral. Regulators are using large-scale data analytics to identify high-risk providers and unusual billing patterns, and federal and state agencies are coordinating more closely to act on those findings. CMS reported in July that its Medicaid Fraud War Room had stopped more than $203 million in potentially improper Medicaid payments involving 50 high-risk providers in its first 88 days.
That changes the enforcement landscape for healthcare businesses, particularly those that depend heavily on government reimbursement.
Data is Changing How Investigations Begin
One of the most significant changes in healthcare fraud enforcement is technological. Artificial intelligence and large-scale data analytics allow regulators and insurers to identify suspicious billing trends and reimbursement anomalies far more quickly than traditional investigations alone.
CMS says its Medicaid Fraud War Room uses advanced analytics to identify suspicious billing patterns, generate investigative leads, and coordinate rapid enforcement actions among federal and state partners. Private insurers have also developed sophisticated Special Investigations Units, or SIUs, to detect suspected fraud and can refer matters to federal law enforcement.
The practical result is that a provider can come under scrutiny because its claims look different from those of its peers, even if the provider does not believe it has done anything improper. Billing data may raise the first question long before an investigator makes contact.
Smaller Problems May No Longer Stay Small
Another important change is the government’s willingness to pursue matters involving smaller amounts of alleged financial harm.
Healthcare organizations may once have viewed relatively small billing discrepancies as unlikely to attract federal attention. That assumption is becoming riskier. When analytics can identify potentially problematic claims at scale, investigators do not need to rely on a single large fraud scheme to find a significant issue. Multiple smaller discrepancies can reveal a broader pattern of conduct.
The consequences can also extend well beyond repayment. Depending on the circumstances, healthcare fraud enforcement can involve civil monetary damages, criminal fines, penalties, incarceration, exclusion from Medicare and Medicaid, and Corporate Integrity Agreements that impose continued regulatory oversight and reporting requirements.
Individual accountability is also part of the equation. Federal enforcement actions increasingly target not only organizations but executives, owners, physicians, and others who may face personal exposure. And because federal agencies can share information subject to applicable legal restrictions, evidence developed in a healthcare fraud matter may become relevant to other government investigations.
The Best Time to Find a Billing Problem: Before the Government Does
Providers and healthcare businesses should be taking proactive compliance measures rather than waiting for an investigation. Internal billing audits, documentation reviews, compliance training, and careful review of referral arrangements can help identify problems before they draw outside scrutiny.
Organizations should also evaluate whether they have clear reporting procedures and appropriate oversight mechanisms. Employees need to know how to raise concerns internally, and organizations need a process for evaluating those concerns when they arise.
When a potential issue has already been identified, early legal advice can help a business assess the circumstances and determine whether remediation, voluntary self-disclosure, or cooperation with investigators may be appropriate.
The goal is not simply to prepare for a government inquiry. It is to understand what the organization’s own billing data would show if regulators analyzed it first.
California May Be An Early Look at What Comes Next
The West Coast Health Care Fraud Strike Force brings together the Department of Justice’s Health Care Fraud Section with U.S. Attorney’s Offices in Arizona, Nevada, and the Northern District of California, working with HHS-OIG, the FBI, the DEA, and other law enforcement partners. Federal officials have said the initiative adds at least 10 prosecutors to healthcare fraud enforcement in the region.
California is particularly important because of the size of its Medicaid program and the federal scrutiny now focused on certain Medicaid spending and provider oversight. The July deferral involving in-home care claims followed federal review of spending growth and claims requiring additional documentation.
The deferrals do not establish that the underlying claims were fraudulent. California has the opportunity to provide documentation showing that the claims meet federal Medicaid requirements. But the government’s willingness to defer substantial federal payments while that review takes place is significant.
For providers, that may be the development worth watching most closely. Scrutiny can begin with billing data, and payment can be affected while questions are still being resolved. In that environment, documentation, billing consistency, and the ability to explain an outlier are not simply compliance exercises. They may determine how quickly a provider can respond when the numbers themselves attract attention.
~~
Katherine “Kate” Bowles is a Director in Fennemore’s Business Litigation practice group. She provides healthcare organizations and businesses with guidance on healthcare disputes and compliance issues. Her background as a Registered Nurse and her legal experience encompass traditional healthcare systems, facilities and health plans, emerging provider types, and trade organizations. Kate can be reached at kbowles@fennemorelaw.com.